홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

나쿼티닙(메실레이트)

Naquotinib Mesylate

HCID 92135932
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
1448237-05-5
표준 SMILES
C=CC(=O)N1CC[C@@H](Oc2nc(Nc3ccc(N4CCC(N5CCN(C)CC5)CC4)cc3)c(C(N)=O)nc2CC)C1.CS(=O)(=O)O
InChIKey
ALDUQYYVQWGTMR-GJFSDDNBSA-N
분자식
C31H46N8O6S
평균 분자량
658.8 g/mol
단동위원소 질량
658.32610239

개요

Naquotinib Mesylate is the mesylate salt form of naquotinib, an orally available, irreversible, third-generation, mutant-selective, epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon oral administration, naquotinib covalently binds to and inhibits the activity of mutant forms of EGFR, including the T790M EGFR mutant, thereby preventing EGFR-mediated signaling. This may both induce cell death and inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization. Naquotinib preferentially inhibits mutated forms of EGFR including T790M, a secondarily acquired resistance mutation, and may have therapeutic benefits in tumors with T790M-mediated resistance when compared to other EGFR tyrosine kinase inhibitors. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced as compared to non-selective EGFR inhibitors which also inhibit wild-type EGFR.

이름 및 식별자

우선 이름
Naquotinib Mesylate
IUPAC
6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide;methanesulfonic acid
현지명
나쿼티닙(메실레이트)
영어명
Naquotinib (mesylate)
분자식
C31H46N8O6S
분자량
658.81194

이름 및 동의어

Naquotinib mesylateASP8273 mesilateASP-8273 mesilateNaquotinib mesilateNaquotinib mesylate [USAN]ASP-8273 MESYLATE12T09LV21ONaquotinib mesilate (JAN)Naquotinib mesylate (USAN)UNII-12T09LV21ONAQUOTINIB MESILATE [JAN]2-Pyrazinecarboxamide, 6-ethyl-3-((4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-(((3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl)oxy)-, methanesulfonate (1:1)
이름 더 보기
나쿼티닙(메실레이트)Naquotinib mesylate (ASP-8273)Naquotinib mesylate (ASP8273 mesylate)EGFR,ASP8273,ErbB-1,ASP 8273,Inhibitor,Naquotinib mesylate,ASP-8273,HER1,Epidermal growth factor receptor,inhibit,Naquotinib
6-Ethyl-3-(4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilino)-5-(((3R)-1-(prop-2-enoyl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide monomethanesulfonate6-Ethyl-3-{4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-{[(3R)-1-(prop-2-enoyl)pyrrolidin-3-yl]oxy}pyrazine-2-carboxamide monomethanesulfonateRefChem:1648221448237-05-5Naquotinib (mesylate)6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide;methanesulfonic acidMFCD30496702ASP8273 (mesylate)

물성

구조 계산 물성보충 중

극성 표면적
183 Ų
수소 결합 공여자 수
3
수소 결합 수용자 수
12
회전 가능 결합 수
9
무거운 원자 수
46
형식 전하
0
복잡도
976

물리화학적 성질

저장 조건
-20 °C · Store at -20°C
용해도
12.5 mg/mL · DMSO : 12.5 mg/mL (18.97 mM)
물리적 상태
Solid
색상
Light yellow to yellow

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성관련 반응화합물 노트

데이터베이스 식별자

CAS
1448237-05-5
PubChem CID
92135932
ChEMBL
CHEMBL3707350
UNII
12T09LV21O